|
Q4 FY2025
As of Dec 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Current assets | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Short-term deposits | |||||||||||||||
| Marketable securities | |||||||||||||||
| Trade accounts receivable, net | |||||||||||||||
| Inventories | |||||||||||||||
| Other current assets | |||||||||||||||
| Total current assets | |||||||||||||||
| Cost | |||||||||||||||
| Less - Accumulated depreciation | |||||||||||||||
| Long-term deposits | |||||||||||||||
| Marketable securities | |||||||||||||||
| Long-term inventory | |||||||||||||||
| Deferred tax asset, net | |||||||||||||||
| Other assets, net | |||||||||||||||
| Property, plant and equipment, net | |||||||||||||||
| Intangible assets, net | |||||||||||||||
| Goodwill | |||||||||||||||
| Total non-current assets | |||||||||||||||
| Total assets | |||||||||||||||
| Liabilities and shareholder's equity | |||||||||||||||
| Current liabilities | |||||||||||||||
| Trade accounts payable | |||||||||||||||
| Due from related parties | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Long-term liabilities | |||||||||||||||
| Deferred tax liabilities, net | |||||||||||||||
| Other long-term liabilities | |||||||||||||||
| Convertible notes | |||||||||||||||
| Total noncurrent liabilities | |||||||||||||||
| Total liabilities | |||||||||||||||
| Shareholders' equity | |||||||||||||||
| Ordinary shares NIS 0.01 par value, 100,000,000 shares authorized at December 31, 2025 and 2024; 47,920,509 and 47,541,682 issued shares at December 31, 2025 and 2024, respectively; 45,828,133 and 45,449,306 shares outstanding at December 31, 2025 and 2024, respectively | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Accumulated other comprehensive income | |||||||||||||||
| Retained earnings | |||||||||||||||
| Total shareholders' equity before treasury stock | |||||||||||||||
| Treasury stock, at cost (2,092,376 shares as of December 31, 2025 and 2024) | |||||||||||||||
| Total shareholders' equity | |||||||||||||||
| Total liabilities and shareholders' equity | |||||||||||||||
Loading...